Patients with FKRP-associated dystroglycanopathy present with phenotypic variability; however, muscle weakness and elevated serum creatine kinase are consistently present [37]. This evidence concerns the gene FKRP and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.